| (CHF) | Dec 2024 | Y/Y change |
|---|---|---|
| Revenue | 1.51K | — |
| Operating expense | — | — |
| Net income | -1.21M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ADXN.SW returned -51.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -49.5% |
| 1 year | -51.2% |
| 5 years | -98.2% |
| 10 years | -99.0% |
| All-time high | CHF 67.50 (Jul 2007) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what CHF1,000 in ADXN.SW would be worth today ›No. Addex Therapeutics Ltd has not paid a dividend in the past 12 months.
Addex Therapeutics Ltd is part of the Healthcare sector.
Addex Therapeutics Ltd has a market cap of 4.25M CHF, based on the latest quote.
Addex Therapeutics Ltd is expected to report earnings around Sep 14, 2026. That date is an estimate and has not been confirmed by the company.